LyondellBasell Industries (LYB) Stock Falls -15.3% Over 30 Days as Index Removal and Analyst Downgrades Hit Hard
Key Takeaways
- LyondellBasell shares fell approximately 15.3% over the past 30 days, dropping from $64.50 on June 5 to $54.60 on July 7, 2026, as multiple headwinds converged on the stock.
- The decline was amplified by the company's removal from the Russell 1000 Defensive Index suite on June 27, triggering repositioning by institutional and rules-based funds.
- Analyst price target cuts from Royal Bank of Canada, Citigroup, and others during the period added downward pressure, with RBC slashing its target from $94 to $65.
- Broader concerns about global petrochemical demand, lingering overcapacity, and the sustainability of war-related margin benefits weighed on investor sentiment.
- Over the quarter, the stock has declined roughly 27%, retreating sharply from its 52-week high of $83.94 reached on March 31, 2026.
Understanding LyondellBasell’s Business and Market Position
LyondellBasell Industries N.V. is one of the world's largest independent chemical companies, operating across five segments: Olefins and Polyolefins - Americas, Olefins and Polyolefins - Europe/Asia/International, Intermediates and Derivatives, Advanced Polymer Solutions, and Technology. The company produces polyethylene, polypropylene, propylene oxide, oxyfuels, and advanced polymers used in packaging, automotive, construction, electronics, and consumer goods. With a market capitalization of approximately $17 billion, LYB is a large-cap materials stock followed closely by investors for its sensitivity to global petrochemical cycles, feedstock costs, and macroeconomic demand trends. The company's cost-advantaged U.S. Gulf Coast assets and its portfolio transformation strategy—including the recent sale of four European sites—are central to its long-term investment narrative.
LYB Stock Performance: 30-Day Decline Compared to the Quarter
Over the last 30 days, LYB shares declined from $64.50 at the close on June 5, 2026, to $54.60 on July 7, 2026—a drop of approximately 15.3%. The selloff was not a single-day event but rather a persistent grind lower, with the stock recording a seven-day losing streak in late June that alone accounted for a cumulative decline of roughly 13%. The stock broke below its 50-day simple moving average in late May and has remained beneath that level throughout the period, while still trading below its 200-day moving average.
Zooming out to the quarterly view, the decline is even steeper. From its 52-week high of $83.94 on March 31, 2026, LYB has fallen approximately 35%. The stock entered the second quarter with strong momentum, buoyed by tightening petrochemical supply due to the Middle East conflict and a Q1 earnings beat. However, that momentum reversed sharply as the quarter progressed, with the stock giving back nearly all of its year-to-date gains. The three-month decline of roughly 27% stands in stark contrast to the S&P 500, which posted gains over the same period.
Factors Behind the Recent 30-Day Selloff in LYB
Several converging factors drove LYB's sharp decline over the past 30 days. The most significant catalyst was the company's removal from the Russell 1000 Value-Defensive Index and the Russell 1000 Defensive Index on June 27, 2026. This reclassification forced rules-based funds and institutional portfolios benchmarked to these defensive indices to rebalance, creating sustained selling pressure. The removal reflected deteriorating metrics in LYB's financial profile, including a 2025 net loss of $745 million and a payout ratio that had turned deeply negative.
Analyst actions compounded the negative sentiment. Royal Bank of Canada lowered its price target from $94 to $65 on July 1, while Citigroup reduced its target from $80 to $67 in late June. Goldman Sachs maintained a sell rating with a $75 target. Weiss Ratings downgraded LYB from "hold" to "sell" on June 24. These revisions highlighted concerns about the durability of petrochemical margin improvements and the company's ability to sustain its reduced dividend.
Insider selling activity also weighed on confidence, with approximately $0.7 million in insider sales recorded over the prior three months and no corresponding buying activity. Additionally, broader macroeconomic uncertainty—including tariff risks, fluctuating crude oil prices, and questions about the pace of global capacity rationalization—kept buyers on the sidelines. While the Middle East conflict has steepened the global petrochemical cost curve in LYB's favor, investors increasingly questioned whether those benefits would persist long enough to offset structural headwinds.
Quarterly Performance Drivers and Market Reassessment
The quarterly decline of roughly 27% reflects a broader reassessment of LYB's risk-reward profile. The stock had rallied sharply earlier in 2026, gaining over 50% year-to-date by late March, as investors priced in the earnings upside from Middle East supply disruptions. The company's Q1 2026 results, reported on May 1, showed adjusted EPS of $0.49—beating estimates by $0.18—and EBITDA excluding identified items of $615 million, nearly 50% above the prior quarter. Management guided for significant sequential improvement in Q2, citing tighter supply dynamics and favorable pricing trends.
Despite the strong operational performance, the market began to focus on risks that the earnings beat had masked. Revenue of $7.2 billion missed analyst estimates of $7.53 billion, declining 6.3% year-over-year. The 50% dividend cut announced earlier in the year—from $1.37 to $0.69 per share—continued to weigh on income-oriented investors. The company's 2025 net loss of $745 million and a payout ratio of -237% underscored the financial strain that preceded the cut. As the quarter progressed, concerns about global overcapacity, particularly in polypropylene, and the potential for demand destruction if polymer prices rose too far, eroded confidence in the sustainability of the margin recovery. The Russell index removal in late June served as a culminating event that crystallized these concerns into accelerated selling.
One Tool That Has Helped Me Navigate Similar Situations
In volatile market environments like the one currently affecting LYB, I often look to data-driven resources for additional perspective. Tickeron’s AI Trading Bots provide a selection of AI-powered strategies that analyze thousands of tickers using technical analysis, pattern recognition, and momentum signals. These tools adapt to changing conditions and highlight approaches that have shown effectiveness in real time, offering a useful complement to traditional fundamental research when assessing how stocks like LYB might behave going forward.
What to Watch for LYB Going Forward
Looking ahead, several factors will determine whether LYB can stabilize and recover. The company's second-quarter 2026 earnings, scheduled for release on July 31, will be a critical checkpoint. Management guided for significant sequential improvement, and investors will scrutinize whether polyethylene and polypropylene pricing gains translated into margin expansion, and whether the Bayport PO/TBA facility restart progressed as planned. Any deviation from guidance could trigger further repositioning.
Geopolitical developments in the Middle East remain a wildcard. CEO Peter Vanacker stated the supply disruption would persist for "multiple quarters, definitely not months," but any progress toward de-escalation could rapidly unwind the cost-curve advantages that have supported LYB's North American and European assets. On the structural side, progress on China's anti-involution policies and the pace of global ethylene capacity rationalizations will shape the medium-term supply-demand balance. The company's Cash Improvement Plan, targeting $500 million in incremental cash flow for 2026, and the integration of the European asset sales will also be closely monitored as indicators of management's ability to strengthen the balance sheet and defend the reduced dividend. Finally, macroeconomic signals—including interest rate trajectories, consumer confidence, and durable goods demand—will influence the demand outlook for LYB's core polymer products.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
LYB's RSI Indicator climbs out of oversold territory
The RSI Oscillator for LYB moved out of oversold territory on July 07, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 22 similar instances when the indicator left oversold territory. In of the 22 cases the stock moved higher. This puts the odds of a move higher at .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on July 10, 2026. You may want to consider a long position or call options on LYB as a result. In of 104 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for LYB just turned positive on July 08, 2026. Looking at past instances where LYB's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LYB advanced for three days, in of 303 cases, the price rose further within the following month. The odds of a continued upward trend are .
LYB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LYB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for LYB entered a downward trend on July 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.858) is normal, around the industry mean (7.265). P/E Ratio (98.766) is within average values for comparable stocks, (43.885). Projected Growth (PEG Ratio) (1.526) is also within normal values, averaging (72.223). LYB's Dividend Yield (0.071) is considerably higher than the industry average of (0.021). P/S Ratio (0.627) is also within normal values, averaging (73.530).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. LYB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LYB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of petrochemicals
Industry ChemicalsSpecialty
Advertisement